C

Cocrystal Pharma
D

COCP

1.61000
USD
0.11
(7.33%)
مغلق
حجم التداول
24
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
16,379,802
أصول ذات صلة
A
ABEO
-0.30500
(-4.45%)
6.55500 USD
A
AEMD
0.00090
(0.24%)
0.37150 USD
A
ALT
0.61000
(11.82%)
5.77000 USD
A
AMRX
0.23500
(3.04%)
7.97000 USD
A
APVO
-0.02420
(-4.85%)
0.47490 USD
A
AXSM
-0.050
(-0.04%)
112.190 USD
B
BNGO
0.04000
(1.00%)
4.04000 USD
C
CAPR
-0.840
(-6.61%)
11.870 USD
C
CLSD
0.02500
(2.95%)
0.87300 USD
C
COLL
0.590
(2.18%)
27.640 USD
C
CPRX
0.570
(2.35%)
24.840 USD
C
CRVS
0.12000
(3.43%)
3.62000 USD
C
CTRM
0.06000
(2.80%)
2.20000 USD
C
CTXR
0.03100
(4.25%)
0.76100 USD
C
CYCC
0.00290
(1.16%)
0.25200 USD
D
DARE
0.02000
(0.68%)
2.95000 USD
D
DMAC
0.04000
(0.96%)
4.22000 USD
D
DRRX
-0.03990
(-6.44%)
0.58010 USD
E
EBS
0.22000
(4.48%)
5.13000 USD
E
ECOR
-0.87000
(-11.40%)
6.76000 USD
E
ENLV
0.00000
(0.00%)
1.04000 USD
E
EQ
-0.00410
(-0.99%)
0.41000 USD
EQT
EQT
1.465
(2.91%)
51.815 USD
E
EVOK
0.18000
(6.19%)
3.09000 USD
E
EYEN
0.10000
(8.77%)
1.24000 USD
F
FATE
0.09000
(7.38%)
1.31000 USD
F
FNKO
0.08500
(2.09%)
4.15500 USD
G
GALT
0.10000
(7.75%)
1.39000 USD
I
IFRX
-0.12900
(-6.94%)
1.73100 USD
I
IMMP
0.08000
(4.88%)
1.72000 USD
I
INO
0.03000
(1.59%)
1.91500 USD
I
IONS
1.100
(3.47%)
32.780 USD
I
IRWD
0.01820
(1.99%)
0.93430 USD
J
JAGX
0.970
(8.16%)
12.860 USD
K
KALA
-0.03000
(-0.79%)
3.79000 USD
L
LADR
0.055
(0.52%)
10.545 USD
L
LCTX
0.00770
(1.59%)
0.49220 USD
L
LGND
0.440
(0.40%)
109.500 USD
L
LPTX
0.00400
(0.96%)
0.42000 USD
L
LTRX
0.06000
(2.74%)
2.25000 USD
L
LXRX
-0.04050
(-5.59%)
0.68450 USD
M
MARA
0.465
(3.32%)
14.485 USD
M
MDGL
-11.63
(-3.55%)
315.49 USD
M
MRUS
-1.140
(-2.51%)
44.210 USD
M
MTNB
0.00040
(0.07%)
0.61000 USD
N
NERV
-0.02000
(-1.14%)
1.73000 USD
N
NEXA
-0.13500
(-2.33%)
5.65000 USD
N
NINE
0.03430
(4.04%)
0.88430 USD
N
NKTR
-0.02630
(-3.38%)
0.75210 USD
NVS
NVS
3.000
(2.69%)
114.320 USD
O
OGEN
0.00150
(0.79%)
0.19190 USD
O
OMER
0.16000
(2.29%)
7.16000 USD
O
ONCY
-0.00240
(-0.44%)
0.54760 USD
O
OVID
0.00410
(1.29%)
0.32250 USD
P
PAVM
-0.03000
(-3.66%)
0.79000 USD
P
PDSB
0.07000
(5.30%)
1.39000 USD
P
PENN
0.425
(2.74%)
15.950 USD
P
PLX
0.00000
(0.00%)
2.99000 USD
P
PTN
-0.00340
(-1.55%)
0.21650 USD
R
RCKT
0.16000
(2.04%)
8.02000 USD
R
RCMT
0.280
(1.62%)
17.610 USD
R
RIGL
0.670
(3.58%)
19.360 USD
R
RMTI
0.14000
(12.96%)
1.22000 USD
S
SAGE
-0.18500
(-2.47%)
7.29000 USD
S
SCYX
0.03900
(3.94%)
1.03000 USD
S
SIGA
0.20000
(3.69%)
5.62000 USD
S
STOK
-0.22800
(-2.31%)
9.63200 USD
T
TGTX
-1.960
(-4.32%)
43.390 USD
T
TNXP
1.955
(10.84%)
19.990 USD
T
TXMD
-0.02000
(-1.40%)
1.41000 USD
U
UBX
0.01500
(1.36%)
1.11500 USD
V
VCEL
1.025
(2.70%)
38.935 USD
V
VCYT
0.635
(2.14%)
30.335 USD
V
VIR
0.08000
(1.32%)
6.15000 USD
V
VKTX
0.775
(2.71%)
29.360 USD
V
VTGN
-0.01000
(-0.42%)
2.37000 USD
V
VTVT
1.640
(7.78%)
22.710 USD
V
VXRT
0.01940
(4.52%)
0.44840 USD
X
XNCR
0.420
(3.87%)
11.270 USD
المزيد
الأخبار المقالات

العنوان: Cocrystal Pharma

القطاع: Healthcare
الصناعة: Biotechnology
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).